SCHEMBL5981402

SCHEMBL5981402

O=S(=O)(Cl)C1Cc2ccccc2O1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HPGD P15428 1/20 0.40
TSHR P16473 1/20 0.40
CA2 P00918 3/20 0.38
NFKB1 P19838 1/20 0.38
NFKB2 Q00653 1/20 0.38
RELA Q04206 1/20 0.38
MAOB P27338 6/20 0.36
AOC2 O75106 5/20 0.36
MAOA P21397 5/20 0.36
CHRM2 P08172 2/20 0.36
CHRM4 P08173 2/20 0.36
CHRM5 P08912 2/20 0.36
CHRM1 P11229 2/20 0.36
CHRM3 P20309 2/20 0.36
DAO P14920 1/20 0.36
HSD17B10 Q99714 2/20 0.35
KDM4E B2RXH2 1/20 0.35
ADORA3 P0DMS8 1/20 0.35
AR P10275 1/20 0.35
CYP19A1 P11511 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30084102 1.00 HPGD (0.40) HPGDTSHRCA2NFKB1NFKB2
SCHEMBL4672085 0.82 CA2 (0.49) CA2CA1
SCHEMBL11072331 0.81 HPGD (0.43) HPGDTSHRCA2NFKB1NFKB2
SCHEMBL7748074 0.81 CA2 (0.44) HPGDTSHRCA2MAOBAOC2
Hydrochloric Acid SCHEMBL28080389 0.80 AOC2 (0.42) HPGDTSHRCA2NFKB1NFKB2
SCHEMBL28897275 0.75 CA2 (0.38) HPGDTSHRCA2MAOBAOC2
SCHEMBL25279034 0.74 CA2 (0.46) HPGDCA2ALDH1A1NISCH
SCHEMBL30464074 0.74 CA2 (0.46) HPGDCA2ALDH1A1NISCH
SCHEMBL30132282 0.73 HPGD (0.34) HPGDTSHRCA2NFKB1NFKB2
SCHEMBL7077595 0.70 MAOB (0.38) HPGDTSHRCA2NFKB1NFKB2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115385862-B Pyrimidine thioether compound containing sulfonate structure and preparation method and application thereof 贵州大学 2023-03-28 CN disclosed
US-7141609-B2 α- and β-amino acid hydroxyethylamino sulfonamides useful as retroviral protease inhibitors G.D. SEARLE & CO. (US) 2006-11-28 US disclosed
US-20050267171-A1 Alpha-and beta-amino acid hydroxyethylamino sulfonamides useful as retroviral protease inhibitors G.D. SEARLE & CO. (US) 2005-12-01 US disclosed
EP-0715618-B1 HYDROXYETHYLAMINO SULPHONAMIDES USEFUL AS RETROVIRAL PROTEASE INHIBITORS SEARLE & CO (US) 1998-12-16 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050267171-A1 Alpha-and beta-amino acid hydroxyethylamino sulfonamides useful as retroviral protease inhibitors DNPEP, ASPH, PREP HPGD 2056/4885TSHR 4734/4885CA2 2248/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.